Jones, Simon A.
Jenkins, Brendan J.
Article History
First Online: 25 September 2018
Competing interests
: B.J.J. has received funding support from Immix Biopharma and Opsona Therapeutics. S.A.J. has received funding support from Ferring Pharmaceuticals, GlaxoSmithKline, Hoffman-La Roche and NovImmune SA, and during the past 5 years, he has acted as an advisory consultant for Chugai Pharmaceuticals, Eleven Biotherapeutics, Genentech, Janssen Pharmaceuticals, Johnson & Johnson, NovImmune SA, Roche and Sanofi Regeneron.